Cloning of TgfβR1 and TgfβR2 and Likely Exclusion as Loci of Origin in a Rabbit Craniosynostotic Model

Abstract

Objective

To determine whether TgfβR1 or TgfβR2 cause the craniosynostotic phenotype in a rabbit model of nonsyndromic craniosynostosis.

Design

Full-length TgfβR1 and TgfβR2 cDNAs were sequenced and real-time reverse-transcription polymerase chain reaction (RT-PCR) was performed to measure TgfβR1 and TgfβR2 transcripts in suturai tissue from wild type (WT) and craniosynostotic (CS) rabbits. Single nucleotide polymorphisms (SNP) were identified within TgfβR1 and TgfβR2 and were assayed for segregation with disease phenotype in 22 craniosynostotic animals.

Results

No structural mutations in TgfβR1 and TgfβR2 were identified in the craniosynostotic rabbits. Real-time RT-PCR quantification of TgfβR1 and TgfβR2 mRNA showed no significant difference in TgfβR1 expression between CS and WT animals, while TgfβR2 showed 50% elevation in the CS animals compared to WT (P < .05). SNP analysis within the TgfβR1 and TgfβR2 genes suggested that neither locus is linked to the craniosynostotic phenotype because no allelic combination showed any specific correlation with disease phenotype for either TgfβR1 or TgfβR2.

Conclusions

Our data indicate that the craniosynostotic phenotype in this rabbit model does not arise from any structural mutation in TgfβR1 or TgfβR2, and SNP analysis also likely excludes these genes more broadly as the site of causative mutation.

Keywords

craniosynostosis rabbit SNP TgfβR1 TgfβR2

Get full access to this article

View all access options for this article.

References

Adès

L.C.

Evolution of the face in Loeys-Dietz syndrome type II: longitudinal observations from infancy in seven cases. Clin Dysmorphol. 2008; 17: 243–248.

Adès

L.C.

Sullivan

Biggin

. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am J Med Genet A. 2006; 140: 1047–1058.

BLAST. Basic Local Alignment Search Tool. Available at http://blast.ncbi.nlm.nih.gov/. Accessed October 3, 2012.

Bonaventure

El Ghouzzi

Molecular and cellular bases of syndromic craniosynostoses. Expert Rev Mol Med. 2003; 5: 1–17.

Bragdon

Moseychuk

Saldanha

King

Julian

Nohe

Bone morphogenetic proteins: a critical review. Cell Signal. 2011; 23: 609–620.

Carinci

Pezzetti

Locci

. Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix. J Craniofac Surg. 2005; 16: 361–368.

Ciurea

A.V.

Toader

Genetics of craniosynostosis: review of the literature. J Med Life 2009; 2: 5–17.

Cohen

MacLean

Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford Press; 2000.

Cohen

M.M.

Jr . Transforming growth factor β, growth factors and their receptors: role in suturai biology and craniosynostosis. J Bone Miner Res. 1997; 12: 322–331.

10.

Cohen

M.M.

Jr . Editorial: perspectives on craniosynostosis. Am J Med Genet A. 2005; 136A: 313–326.

11.

Cooper

G.M.

Curry

Barbano

T.E.

. Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J Bone Miner Res. 2007; 22: 1046–1054.

12.

Cray

Jr Burrows

A.M.

Vecchione

Caccamese

J.F.

Jr Losee

J.E.

Moursi

A.M.

Siegel

M.I.

Cooper

G.M.

Mooney

M.P.

Blocking bone morphogenetic protein function using in vivo noggin therapy does not rescue premature suture fusion in rabbits with delayed-onset craniosynostosis. Plast Reconstr Surg. 2011a; 127: 1163–1172.

13.

Cray

J.J.

Jr Gallo

P.H.

Durham

E.L.

Losee

J.E.

Mooney

M.P.

Kathju

Cooper

G.M.

Molecular analysis of coronal perisutural tissues in a craniosynostotic rabbit model using polymerase chain reaction suppression subtractive hybridization. Plast Reconstr Surg. 2011b; 128: 95–103.

14.

de Ravel

T.J.

Taylor

I.B.

Van Oostveldt

A.J.

Fryns

J.P.

Wilkie

A.O.

A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome. Eur J Hum Genet. 2005; 13: 503–505.

15.

Doherty

E.S.

Lacbawan

Hadley

D.W.

. Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet A. 2007; 143A: 3204–3215.

16.

Ensembl. Ensembl genome browser. Available at http://www.ensembl.org/index.html. Accessed October 3, 2012.

17.

Esparza

Hinojosa

Complications in the surgical treatment of craniosynostosis and craniofacial syndromes: apropos of 306 transcranial procedures. Childs Nerv Syst. 2008; 24: 1421–1430.

18.

Glaser

R.L.

Jiang

Boyadjiev

S.A.

. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet. 2000; 66: 768–777.

19.

Ibrahimi

O.A.

Eliseenkova

A.V.

Plotnikov

A.N.

Ornitz

D.M.

Mohammadi

Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A. 2001; 98: 7182–7187.

20.

Jamsheer

Henggeler

Wierzba

. A new sporadic case of early-onset Loeys-Dietz syndrome due to the recurrent mutation p.R528C in the TGFBR2 gene substantiates interindividual clinical variability. J Appl Genet. 2009; 50: 405–410.

21.

Kathju

Satish

Rabik

Rupert

Oswald

Johnson

F.Z.

Post

J.C.

Ehrlich

Identification of differentially expressed genes in scarless wound healing utilizing polymerase chain reaction-suppression subtractive hybridization. Wound Repair Regen. 2006; 14: 413–420.

22.

Liu

Wang

Yuan

Bao

Chu

Molecular cloning, in vitro expression and bioactivity of rabbit transforming growth factor-beta receptor type II (rTGF-βRII). Vet Immunol Immunopathol. 2011; 140: 55–62.

23.

Loeys

B.L.

Chen

Neptune

E.R.

. A syndrome of altered cradiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFβR1 or TGFβR2. Nat Genet. 2005; 37: 275–281.

24.

Maxson

Ishii

The BMP pathway in skull vault development. Front Oral Biol. 2008; 12: 197–208.

25.

Melville

Wang

Taub

P.J.

Jabs

E.W.

Genetic basis of potential therapeutic strategies for craniosynostosis. Am J Med Genet Part A. 2010; 152A: 3007–3015.

26.

Mooney

M.P.

Aston

C.E.

Siegel

M.I.

. Craniosynostosis with autosomal dominant transmission in New Zealand white rabbits. J Craniofac Genet Dev Biol. 1996a; 16: 52–63.

27.

Mooney

M.P.

Losken

H.W.

Moursi

A.M.

. Anti-TGF[beta]2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Plast Reconstr Surg. 2007; 119: 1200–1212.

28.

Mooney

M.P.

Losken

H.W.

Siegel

M.I.

Lalikos

J.F.

Losken

Burrows

A.M.

Smith

T.D.

Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis. Part I: breeding demographics, inheritance pattern, and craniofacial anomalies. Cleft Palate Craniofac J. 1994a; 31: 1–7.

29.

Mooney

M.P.

Losken

H.W.

Siegel

M.I.

Lalikos

J.F.

Losken

Burrows

A.M.

Smith

T.D.

Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis. Part II: somatic and craniofacial growth patterns. Cleft Palate Craniofac J. 1994b; 31: 8–16.

30.

Mooney

M.P.

Shand

Mitchell

. Suture fusion rescue with Tgf-β2 antibody in craniosynostotic rabbits. J Dent Res. 2004; 83(spec. issue A): 2558.

31.

Mooney

M.P.

Siegel

M.I.

Burrows

A.M.

Smith

T.D.

Losken

H.W.

Dechant

Cooper

Kapucu

M.R.

A rabbit model of human familial, nonsyndromic unicoronal suture synostosis. I. Synostotic onset, pathology, and suturai growth patterns. Childs Nerv Syst. 1998a; 14: 236–246.

32.

Mooney

M.P.

Siegel

M.I.

Burrows

A.M.

. A rabbit model of human familial, nonsyndromic unicoronal suture synostosis. II. Intracranial contents, intracranial volume, and intracranial pressure. Childs Nerv Syst. 1998b; 14: 247–255.

33.

Mooney

M.P.

Smith

T.D.

Burrows

A.M.

Langdon

H.L.

Stone

C.E.

Losken

H.W.

Caruso

Siegel

M.I.

Coronal suture pathology and synostotic progression in rabbits with congenital craniosynostosis. Cleft Palate Craniofac J. 1996b; 33: 369–378.

34.

Moore

Persaud

Before We Are Born: Essentials of Embryology and Birth Defects. St. Louis: Saunders, 2007.

35.

Morriss-Kay

G.M.

Wilkie

A.O.

Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat. 2005; 207: 637–653.

36.

Nie

Luukko

Kettunen

FGF signaling in craniofacial development and developmental disorders. Oral Dis. 2006; 12: 102–111.

37.

Opperman

L.A.

Cranial sutures as intramembranous bone growth sites. Dev Dyn. 2000; 219: 472–485.

38.

Opperman

L.A.

Chhabra

Cho

R.W.

Ogle

R.C.

Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol. 1999; 19: 164–173.

39.

Opperman

L.A.

Nolen

A.A.

Ogle

R.C.

TGF-β1, TGF-β2, and TGF-β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res. 1997; 12: 301–310.

40.

Opperman

L.A.

Ogle

R.C.

Molecular studies of craniosynostosis: factors affecting cranial suture morphogenesis and patency. In: Mooney

M.P.

Siegel

M.I.

, eds. Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostosis and Facial Clefting. New York: John Wiley and Sons; 2002: 497–518.

41.

Passos-Bueno

M.R.

Serti Eacute

A.E.

Jehee

F.S.

Fanganiello

Yeh

Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. Front Oral Biol. 2008; 12: 107–143.

42.

Persing

J.A.

Management considerations in the treatment of craniosynostosis. Plast Reconstr Surg. 2008; 121(4 Suppl): 1–11.

43.

Poisson

Sciote

J.J.

Koepsel

Cooper

G.M.

Opperman

L.A.

Mooney

M.P.

Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac J. 2004; 41: 392–402.

44.

Roth

D.A.

Gold

L.I.

Han

V.K.

McCarthy

J.G.

Sung

J.J.

Wisoff

J.H.

Longaker

M.T.

Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg. 1997a; 99: 3.

45.

Roth

D.A.

Longaker

M.T.

McCarthy

J.G.

Rosen

D.M.

McMullen

H.F.

Levine

J.P.

Sung

Gold

L.I.

Studies in cranial suture biology: part I. Increased immunoreactivity for TGF-β isoforms (β1, β2, and β3) during rat cranial suture fusion. J Bone Miner Res. 1997b; 12: 311–321.

46.

Shi

Massague

Mechanisms of TGF-B signaling from cell membrane to nucleus. Cell. 2003; 113: 685–700.

47.

Sperber

Craniofacial Development. Shelton, CT: People's Medical Publishing House; 2001.

48.

van Steensel

M.A.

van Geel

Parren

L.J.

Schrander-Stumpel

C.T.

Marcus-Soekarman

Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2. Exp Dermatol. 2008; 17: 362–365.

49.

Vogels

Fryns

J.P.

Pfeiffer syndrome. Orphanet J Rare Dis. 2006; 1: 19.

50.

Wilkie

A.O.

Craniosynostosis: genes and mechanisms. Hum Mol Genet. 1997; 6: 1647–1656.